MediPharm Labs Corp.
MEDIF
$0.0554
-$0.0046-7.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.53M | 7.53M | 8.60M | 7.18M | 7.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.53M | 7.53M | 8.60M | 7.18M | 7.56M |
| Cost of Revenue | 6.10M | 4.62M | 5.84M | 4.83M | 4.95M |
| Gross Profit | 2.44M | 2.91M | 2.77M | 2.36M | 2.62M |
| SG&A Expenses | 5.18M | 3.28M | 3.09M | 4.00M | 4.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -56.40K | -115.70K | -90.70K | 150.30K | 24.10K |
| Total Operating Expenses | 11.25M | 7.84M | 8.88M | 9.07M | 9.33M |
| Operating Income | -2.72M | -305.90K | -276.50K | -1.89M | -1.76M |
| Income Before Tax | -2.72M | -269.70K | -1.23M | -2.03M | -1.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.72M | -269.70K | -1.23M | -2.03M | -1.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.72M | -269.70K | -1.23M | -2.03M | -1.89M |
| EBIT | -2.72M | -305.90K | -276.50K | -1.89M | -1.76M |
| EBITDA | -2.42M | -16.00K | 112.90K | -1.51M | -1.23M |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 415.35M | 415.12M | 411.83M | 411.07M | 404.78M |
| Average Diluted Shares Outstanding | 415.35M | 415.12M | 411.83M | 411.07M | 404.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |